Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,2202,248,1.70 [1.24-2.32],0.0008667419604501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,2659,312,1.55 [1.14-2.09],0.0046750539548166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",2603,303,1.53 [1.31-1.79],7.899582006033697e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,2585,303,1.32 [1.06-1.64],0.0143353980862257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2633,311,2.71 [2.02-3.64],2.935032206091891e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,2626,305,1.69 [1.39-2.06],1.7308437082245796e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2214,250,1.50 [1.10-2.06],0.0113721392367074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2634,311,1.45 [1.12-1.90],0.0056454046090962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2674,311,1.45 [1.07-1.96],0.016121910566472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2268,253,2.21 [1.58-3.08],2.9625914735425124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,2633,311,1.99 [1.57-2.52],1.5728509553847177e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,2665,309,1.91 [1.39-2.61],5.313569955445373e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,2666,313,2.01 [1.54-2.62],2.465384896006869e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,2639,307,1.22 [1.13-1.33],1.681752123238047e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,2648,308,0.54 [0.38-0.77],0.0005493894054825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,2242,246,0.84 [0.73-0.98],0.0229401474074678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2603,303,0.87 [0.78-0.98],0.0211278055277623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,2668,312,2.21 [1.52-3.21],3.412201284602759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,2278,252,0.31 [0.18-0.51],5.971395406935761e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,2626,310,0.68 [0.58-0.80],2.050524640656464e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,2564,298,1.22 [1.11-1.34],3.063938297798612e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,2578,300,1.29 [1.09-1.53],0.0029629709288766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,2665,309,1.65 [1.30-2.09],3.3728826197368766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,2674,311,1.28 [1.06-1.56],0.0107235180286421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,2230,249,1.53 [1.11-2.09],0.0085257062815115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,2679,313,1.82 [1.16-2.86],0.0092748580319202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,2214,250,1.13 [1.03-1.24],0.013150242381203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",2639,307,1.12 [1.02-1.24],0.0148012966580168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,2667,312,3.20 [2.05-4.99],2.859778931590025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,2639,307,1.57 [1.05-2.34],0.0270420068400383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,2242,246,0.68 [0.50-0.93],0.0162366543340835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,2643,307,1.72 [1.31-2.26],0.0001073049246165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,2668,312,1.31 [1.01-1.70],0.0392927535703445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,2604,304,1.49 [1.06-2.08],0.0218890506379461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,2651,307,0.75 [0.58-0.97],0.0276799569984154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,2660,308,1.60 [1.28-1.99],3.649414963247824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,2668,312,1.35 [1.06-1.72],0.0156232245932901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,2576,301,1.69 [1.32-2.16],2.984420077616944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,2655,309,3.03 [2.22-4.13],3.345243428274192e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,2252,251,0.66 [0.46-0.93],0.0163949546056062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,2648,308,0.79 [0.65-0.96],0.0167814667690895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,2278,252,0.43 [0.27-0.70],0.0006168193729024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,2287,256,1.49 [1.20-1.85],0.0003277796428849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,2278,252,2.55 [1.93-3.36],3.868634639889207e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,2230,249,0.74 [0.56-0.99],0.0397920228049681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,2274,252,0.55 [0.39-0.76],0.0003511022806276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,2173,241,0.68 [0.48-0.96],0.0270117025758501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,2278,252,0.71 [0.56-0.90],0.004202721464015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,2287,256,0.76 [0.60-0.95],0.0180297723651446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,2653,308,0.63 [0.46-0.86],0.004429027505691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,2639,307,1.92 [1.60-2.30],1.7534652594833437e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,2206,248,1.22 [1.05-1.43],0.0111254101626132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,2655,309,1.69 [1.32-2.17],3.2395567626571584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,2634,311,1.74 [1.29-2.35],0.0003107269254809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,2287,256,1.90 [1.28-2.82],0.0014405931415768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2202,248,1.47 [1.12-1.91],0.0050210667330974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",2581,302,1.19 [1.01-1.40],0.0370083695753605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2268,253,2.09 [1.52-2.88],5.599647695986705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,2655,309,1.63 [1.16-2.29],0.004654789114207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,2278,252,2.07 [1.48-2.88],1.7275628553137344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2230,249,2.25 [1.63-3.11],7.809608908154479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2665,309,1.93 [1.36-2.73],0.0002213461828712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,2646,311,0.85 [0.74-0.99],0.0339406889813346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2583,300,1.85 [1.39-2.45],2.011045111750713e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,2661,313,1.56 [1.05-2.31],0.026445625078125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,2634,311,0.46 [0.35-0.60],1.0380322977411904e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2646,311,1.52 [1.17-1.99],0.002032881934465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,2286,255,0.73 [0.65-0.82],1.582973217159697e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,2242,246,2.07 [1.48-2.89],2.041675547676987e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,2242,246,2.23 [1.39-3.58],0.0009343855027846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,2603,303,2.70 [1.81-4.03],1.0480133718009978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,2581,302,1.44 [1.16-1.79],0.0011372296584866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,2669,311,2.15 [1.41-3.29],0.0003936675629445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,2665,309,2.41 [1.82-3.21],1.1249035740296855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,2661,309,1.81 [1.21-2.72],0.0042287196086603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,2214,250,0.72 [0.53-0.96],0.0252307605720409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2655,309,1.22 [1.00-1.48],0.0493943741467623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2239,245,0.77 [0.61-0.98],0.0306482342423072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,2278,252,0.43 [0.20-0.94],0.0337839452029284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,2653,308,1.92 [1.17-3.14],0.0098004203353579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,2219,248,2.29 [1.66-3.15],4.2023662855283364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,2278,252,0.55 [0.37-0.82],0.0032254056239243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,2639,307,2.73 [2.12-3.52],6.919618184165904e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,2668,312,1.61 [1.26-2.06],0.0001608430332107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,2677,312,1.19 [1.02-1.40],0.0282804185757422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,2679,313,1.56 [1.08-2.25],0.0185590901650586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,2668,312,1.50 [1.27-1.77],1.7961476135219632e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2206,248,1.25 [1.04-1.50],0.0155348149106696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,2581,302,1.80 [1.36-2.37],3.724127086942637e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,2631,310,1.33 [1.16-1.53],4.600454421204067e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,2278,254,1.44 [1.17-1.77],0.0006628555661015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,2629,308,1.18 [1.00-1.40],0.0476232184448237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,2668,312,0.71 [0.53-0.95],0.0209609746837447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,2278,254,1.22 [1.02-1.47],0.0325158378578834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,2674,311,1.89 [1.45-2.48],3.447320599334101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,2643,307,1.44 [1.14-1.83],0.002633216526538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,2679,313,1.63 [1.34-1.98],1.0676485976837673e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,2665,309,1.26 [1.06-1.51],0.0094953170380686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,2674,311,1.81 [1.47-2.24],2.5031818024005764e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,2637,309,1.19 [1.01-1.39],0.0346051456324183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,2672,313,1.53 [1.20-1.96],0.0006998919329466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,2668,312,1.57 [1.25-1.99],0.0001423037104536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,2661,313,1.67 [1.32-2.12],2.5425787088528947e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,2268,253,1.36 [1.06-1.75],0.0160141112445662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,2661,313,1.56 [1.18-2.07],0.001861537426016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,2608,304,1.54 [1.22-1.94],0.0002547180376535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,2674,311,1.74 [1.45-2.09],2.628719417636218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2655,309,1.42 [1.14-1.77],0.0016408356889153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,2661,313,1.52 [1.22-1.89],0.0001812024195076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,2658,311,0.57 [0.39-0.83],0.0037558439863507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,2646,311,1.45 [1.05-2.01],0.0226059384440762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,2599,307,1.65 [1.30-2.11],4.7621023810107474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,2658,311,2.08 [1.72-2.52],9.411664622551153e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,2634,311,1.47 [1.15-1.88],0.0023261193664439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,2649,308,2.67 [2.09-3.42],3.293925611908431e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,2583,300,1.79 [1.40-2.29],3.7971367228508497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,2673,312,1.82 [1.40-2.37],6.885187707248966e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,2658,309,1.47 [1.18-1.83],0.0005758960046832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,2668,312,1.26 [1.07-1.48],0.0052360747724743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,2639,307,2.33 [1.82-2.98],2.4579692420085843e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2639,307,1.67 [1.27-2.20],0.0002699230741283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,2642,310,1.61 [1.24-2.10],0.000372952796457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,2652,308,1.27 [1.06-1.54],0.0116766980103085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,2633,305,1.76 [1.27-2.44],0.0006353062806537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,2660,308,1.76 [1.28-2.42],0.0004471171479851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,2667,312,1.65 [1.30-2.11],4.86920710933914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,2551,297,1.78 [1.29-2.46],0.0004012834426317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,2533,299,2.22 [1.58-3.12],4.602511925719024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,2208,249,1.44 [1.13-1.85],0.0034811396281837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,2673,312,2.15 [1.65-2.79],1.2131741820587225e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2674,311,1.58 [1.30-1.93],4.8816117679142975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,2273,252,1.49 [1.09-2.04],0.012291292512311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,2646,311,1.48 [1.14-1.92],0.0035302841166423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2673,312,1.21 [1.01-1.44],0.0338664937025459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,2570,297,1.56 [1.16-2.09],0.0036021326306788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,2661,313,2.41 [1.54-3.79],0.0001324460863542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,2271,252,0.75 [0.58-0.97],0.0296512656436179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,2547,296,2.00 [1.69-2.38],1.230062082791701e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,2670,311,1.26 [1.12-1.42],9.651342085982772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,2648,308,1.40 [1.24-1.58],5.4133686907324256e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,2673,312,1.59 [1.26-2.03],0.0001329303255495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,2648,308,1.46 [1.15-1.86],0.0017551682638045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,2639,307,0.81 [0.71-0.93],0.0028527049388577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,2639,307,1.41 [1.16-1.71],0.000522808212688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2656,308,1.47 [1.01-2.14],0.0434652935188167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,2663,311,1.39 [1.12-1.72],0.0027876219350529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2646,311,1.18 [1.06-1.32],0.0023373581845297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2557,299,1.20 [1.04-1.40],0.0157184030006276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,2251,250,1.18 [1.02-1.37],0.0297022995442431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,2657,310,0.87 [0.79-0.97],0.0091849665626422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,2639,307,1.33 [1.12-1.56],0.0007688215617264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,2583,300,1.25 [1.04-1.51],0.0190371734532414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,2259,249,1.27 [1.02-1.60],0.0360388668010792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,2278,252,0.44 [0.25-0.78],0.004693733913311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,2661,313,1.34 [1.15-1.55],0.000148379570936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2287,256,1.64 [1.19-2.27],0.002768603301952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2648,308,1.58 [1.28-1.93],1.2860242399896666e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,2242,246,0.55 [0.44-0.69],9.44258492887281e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2278,254,2.08 [1.64-2.63],1.3581299588607915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,2286,255,1.16 [1.06-1.27],0.0020256902880068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,2664,310,1.61 [1.31-1.97],4.429865138834328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,2592,305,1.21 [1.08-1.35],0.0009082482983112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,2650,308,1.43 [1.06-1.93],0.0188730662869715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,2660,308,1.66 [1.25-2.20],0.0005301862429588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,2286,255,1.50 [1.21-1.86],0.0001924723315267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,2662,311,2.08 [1.63-2.65],3.657456939597702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,2286,255,1.44 [1.21-1.72],5.909469619733815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2640,308,1.34 [1.14-1.57],0.0003229292705203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,2645,308,1.20 [1.04-1.39],0.0155237489221358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,2634,311,1.36 [1.03-1.79],0.0304776303864109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,2661,313,1.84 [1.40-2.40],9.668686932305038e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,2603,303,1.57 [1.21-2.04],0.0007437819699468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,2234,253,1.29 [1.04-1.60],0.0192526537407442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,2215,240,0.31 [0.18-0.53],1.8470996098367843e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,2646,311,0.73 [0.60-0.89],0.001674729731746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,2646,311,1.18 [1.02-1.37],0.025591498489838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,2641,308,1.64 [1.21-2.24],0.0016081169388802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,2674,311,1.51 [1.24-1.84],4.6996755324202166e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,2668,312,2.14 [1.43-3.20],0.0001990826771529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,2679,313,1.49 [1.05-2.11],0.024230117266503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,2668,312,1.33 [1.08-1.64],0.0084662345419503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,2653,313,2.76 [1.91-4.00],6.223738474924215e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,2679,313,0.62 [0.41-0.93],0.0202598496113004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,2648,308,1.73 [1.41-2.11],9.732462074575858e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,2679,313,1.90 [1.52-2.36],1.3216441474466517e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,2649,308,2.28 [1.67-3.10],1.768919424405977e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,2669,311,1.56 [1.38-1.77],8.29444640198016e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,2657,307,1.40 [1.07-1.83],0.0134377690284208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2214,250,0.61 [0.38-0.98],0.0415372287115067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,2665,312,1.33 [1.03-1.72],0.0294902378276368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,2273,252,1.54 [1.01-2.35],0.0443442073586651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,2625,307,0.64 [0.49-0.82],0.0004831779561999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,2665,309,1.88 [1.19-2.98],0.0065145605431911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,2634,311,1.44 [1.11-1.88],0.0069301451604845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,2668,312,0.85 [0.73-0.99],0.0371843349080769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,2269,253,0.40 [0.26-0.62],4.8663986400605054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2634,311,1.27 [1.05-1.54],0.014813633562382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,2665,309,1.86 [1.33-2.62],0.0003109189570917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,2287,256,1.33 [1.00-1.75],0.0474475270620375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,2286,255,1.76 [1.25-2.48],0.0011344920995463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,2648,309,1.96 [1.48-2.60],3.0457842507219244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,2610,309,1.29 [1.08-1.52],0.0037560098265605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,2614,303,1.42 [1.13-1.80],0.0031199532618086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2286,255,1.64 [1.15-2.33],0.0058818792069454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,2655,308,0.84 [0.73-0.95],0.0065742518632083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,2242,246,1.48 [1.19-1.83],0.0004485250950203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,2599,303,1.16 [1.01-1.33],0.0374748605061903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,2648,308,1.94 [1.34-2.80],0.0004676531937832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,2674,311,1.70 [1.27-2.28],0.0003799434084483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,2086,230,2.07 [1.23-3.48],0.0060084974669304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,2647,308,1.66 [1.26-2.20],0.0003470296347742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2234,253,1.30 [1.10-1.54],0.0020534721368093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,2634,311,1.56 [1.20-2.03],0.0008063464121672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,2646,311,1.32 [1.09-1.60],0.004245834723967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,2622,307,1.19 [1.04-1.35],0.0116357614933149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,2665,309,1.26 [1.09-1.44],0.0011530047649008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2658,311,2.23 [1.73-2.89],9.932840269800755e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,2199,248,0.57 [0.37-0.88],0.0104268357451904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,2603,303,2.98 [2.08-4.25],1.989378731842941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,2658,311,0.78 [0.65-0.93],0.0069276087818524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,2673,312,1.55 [1.06-2.28],0.0247782501917337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,2268,253,1.26 [1.00-1.58],0.0495385484567923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,2234,253,1.51 [1.17-1.94],0.0013355860670317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,2583,300,0.76 [0.62-0.93],0.0092540408194285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,2201,249,1.34 [1.10-1.64],0.004144576896064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,2630,310,1.71 [1.42-2.06],1.488936249842268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,2658,311,2.37 [1.81-3.10],4.3929980094758757e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,2230,249,0.62 [0.52-0.73],4.979138564561346e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,2639,307,1.41 [1.02-1.96],0.0397423541419142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2639,307,1.71 [1.32-2.20],3.704616217605886e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,2659,312,1.26 [1.07-1.48],0.0049772633374472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,2633,307,2.42 [1.89-3.12],4.8007825116370046e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,2661,313,1.93 [1.43-2.59],1.5211208470437194e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,2633,307,0.68 [0.55-0.82],0.0001169366576377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,2261,247,1.40 [1.08-1.82],0.0108411235511757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2639,307,2.03 [1.39-2.97],0.0002808405331693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,2663,312,1.78 [1.30-2.44],0.0003406019114779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2668,312,2.18 [1.81-2.63],2.3915008093196943e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2603,303,1.60 [1.23-2.09],0.0004699273275567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,2230,249,1.98 [1.34-2.90],0.0005364740297803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2268,253,2.07 [1.46-2.93],4.663954452908699e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2652,309,1.75 [1.32-2.31],8.749510374690555e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,2274,254,1.47 [1.10-1.98],0.0104381612268652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,2659,313,2.41 [1.85-3.14],4.974355932846084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,2633,311,2.71 [2.16-3.40],7.520327615618367e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,2234,253,1.30 [1.11-1.52],0.0013624337285951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2230,249,1.46 [1.05-2.03],0.0259979399460212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,2660,309,1.34 [1.01-1.79],0.0443991120363225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,2553,298,2.41 [1.93-3.01],5.183817616711641e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,2679,313,2.50 [1.83-3.40],6.5792323809697e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,2631,310,1.49 [1.14-1.97],0.0040465148865724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,2646,311,1.30 [1.16-1.45],6.187513503280708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2664,312,1.74 [1.33-2.28],4.863404036893833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2658,311,1.65 [1.17-2.31],0.0039159795559523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,2214,250,1.46 [1.11-1.93],0.0067911772995949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,2679,313,1.59 [1.21-2.10],0.0009364505295865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,2202,248,0.74 [0.56-0.97],0.0291802208942221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,2660,308,1.23 [1.02-1.47],0.0268135407349201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,2653,311,1.57 [1.12-2.20],0.0083735368557369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",2649,308,1.24 [1.12-1.37],1.710901443028242e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",2648,308,1.20 [1.07-1.35],0.0019213307186274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",2273,252,1.52 [1.26-1.84],9.295598245503144e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",2679,313,1.62 [1.39-1.89],4.6218312486660814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,2664,309,1.26 [1.08-1.46],0.0027804085643937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,2639,307,2.25 [1.70-2.99],1.7996203315159542e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,2647,307,2.93 [2.24-3.83],4.45788398831392e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,2268,253,1.48 [1.29-1.70],1.5642765545406117e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,2671,313,1.46 [1.15-1.86],0.0020601911498893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",2648,308,0.87 [0.76-0.99],0.0359776765948901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,2633,306,0.68 [0.54-0.86],0.001638384067997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,2583,300,1.21 [1.04-1.42],0.0165123264811813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,2663,312,1.29 [1.12-1.50],0.0006207629138035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,2585,303,2.16 [1.64-2.84],3.7580288725217786e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,2658,311,0.52 [0.39-0.69],4.612739369080167e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,2286,255,0.61 [0.48-0.77],2.842177549275936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,2278,254,0.59 [0.43-0.82],0.0014496258036411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,2287,256,1.23 [1.03-1.47],0.0204785918633249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2634,311,1.67 [1.22-2.28],0.001188978995741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,2674,311,1.36 [1.02-1.82],0.0364864132277643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,2658,311,0.70 [0.53-0.93],0.0140739973074975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,2278,252,0.39 [0.25-0.62],5.216609799189721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,2644,310,1.60 [1.18-2.17],0.0027899697995141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,2673,312,1.62 [1.18-2.24],0.0032860356083739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,2230,249,1.39 [1.10-1.74],0.004738345941079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,2230,249,2.87 [1.74-4.74],3.591382495364448e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,2649,307,1.89 [1.47-2.44],7.892576372739063e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,2272,252,0.87 [0.77-0.98],0.023686235377863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,2242,246,0.77 [0.64-0.92],0.0046355702711383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,2658,311,0.59 [0.44-0.80],0.0005657100064974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2673,312,1.27 [1.03-1.55],0.0243878288643432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2639,307,1.63 [1.16-2.28],0.0049792462573554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2585,303,1.59 [1.28-1.97],2.252791814063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,2639,307,1.62 [1.02-2.58],0.041504759367225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,2275,253,0.84 [0.71-0.99],0.0419902597632218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,2583,300,1.22 [1.13-1.31],5.928669514245309e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2639,307,1.51 [1.14-2.01],0.0042618471279604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,2679,313,2.04 [1.78-2.32],4.466097791175809e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,2648,308,1.34 [1.03-1.75],0.0315043685125589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,2581,302,1.41 [1.09-1.80],0.0075508639574258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,2663,312,2.62 [1.97-3.48],3.916178446190296e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,2625,309,1.64 [1.18-2.28],0.0035227237744362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,2634,311,2.78 [1.94-3.98],2.430556044460888e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,2647,307,1.10 [1.04-1.17],0.0013655134758234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,2242,246,0.44 [0.29-0.67],0.0001146207595179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,2230,249,1.35 [1.11-1.64],0.0024311235017482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,2278,254,1.63 [1.16-2.30],0.0053190929621095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,2199,248,1.24 [1.07-1.44],0.0048377477383825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,2541,292,1.65 [1.17-2.33],0.0041836737805011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,2206,248,1.39 [1.07-1.81],0.0147021912876171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,2235,251,1.60 [1.24-2.07],0.0003008070659075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2242,246,0.71 [0.50-0.99],0.0449913006479884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2286,255,0.69 [0.53-0.91],0.0083129787204318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,2637,305,0.70 [0.52-0.95],0.0204509216361528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2574,300,1.11 [1.01-1.23],0.0341919312697127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,2639,307,0.91 [0.84-0.98],0.0118390723312075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,2668,312,1.64 [1.20-2.26],0.0020954367394415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,2634,311,0.82 [0.69-0.98],0.030012793915069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,2588,299,2.64 [1.88-3.69],1.7477538588965243e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,2603,303,1.35 [1.17-1.56],4.856941012832428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,2648,313,2.45 [1.69-3.56],2.2597801312860494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,2645,308,0.86 [0.76-0.96],0.0085293957482929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,2652,312,1.91 [1.54-2.38],6.895275568957108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",2603,303,0.88 [0.78-0.99],0.0353632080340754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,2646,311,0.83 [0.70-0.99],0.038229281054242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,2667,312,1.69 [1.50-1.89],4.7327557089065335e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,2661,313,1.69 [1.31-2.18],5.693327303489108e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,2273,252,3.41 [2.18-5.33],8.067711870568957e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,2273,253,1.25 [1.01-1.55],0.0399699272642923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2274,254,1.57 [1.09-2.28],0.015725134566415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2646,311,1.94 [1.48-2.55],1.6894951497086949e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,2629,305,0.70 [0.57-0.86],0.0005868280594662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2230,249,1.48 [1.16-1.87],0.0014438078783354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,2230,249,1.15 [1.01-1.31],0.0385890040707661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,2267,249,1.47 [1.07-2.02],0.0180613527228064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,2668,312,1.66 [1.34-2.07],4.77306155186846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2626,304,1.82 [1.36-2.44],6.041942057611679e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,2627,302,1.86 [1.27-2.72],0.0013274566895191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,2679,313,1.50 [1.01-2.22],0.0426021672475052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,2679,313,1.37 [1.01-1.85],0.0434348172799718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,2639,307,1.75 [1.06-2.88],0.0284280399202492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,2585,303,1.10 [1.00-1.22],0.0393347984834297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,2665,309,1.95 [1.29-2.96],0.0017004196829086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,2581,302,1.24 [1.01-1.52],0.0352904819819973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,2639,307,2.03 [1.38-3.01],0.0003813813349076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,2677,312,1.10 [1.01-1.19],0.0300526749444168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,2674,313,1.40 [1.21-1.61],3.224446668494016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,2655,309,0.66 [0.53-0.83],0.000400378386387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,2635,309,1.69 [1.44-1.99],8.369032210723421e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,2638,306,1.69 [1.32-2.17],2.831523169070025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,2679,313,1.41 [1.09-1.83],0.0083328028127329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2648,308,1.40 [1.10-1.78],0.0063762201106331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,2202,248,1.44 [1.18-1.77],0.0004420486669231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,2648,308,1.65 [1.27-2.15],0.0001954048222455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,2273,252,0.88 [0.78-1.00],0.0432670900765931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,2665,309,1.64 [1.22-2.21],0.001174930613399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,2639,307,1.20 [1.07-1.34],0.0019772960951536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,2674,311,1.27 [1.07-1.50],0.0058104955207107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2585,303,1.45 [1.12-1.87],0.0051248036949734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,2646,311,1.77 [1.34-2.36],7.453757542886562e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,2585,303,1.47 [1.11-1.94],0.0069307797524312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,2585,303,1.35 [1.22-1.50],7.302774810656445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,2585,303,1.15 [1.02-1.31],0.0249236368157986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,2621,308,1.31 [1.08-1.57],0.0049211953314675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,2642,308,1.25 [1.00-1.56],0.0464282552361724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,2655,309,1.93 [1.46-2.54],3.3299500361537385e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,2674,311,1.51 [1.14-2.00],0.0038646158206874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,2597,301,1.14 [1.01-1.29],0.0371178879260103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,2585,303,1.18 [1.02-1.36],0.0300736549893706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,2659,313,3.63 [2.58-5.10],1.139675594266247e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,2671,313,1.77 [1.41-2.22],6.910427451638597e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,2624,305,1.56 [1.26-1.95],6.553004472887461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,2646,311,1.56 [1.23-1.98],0.0002212876046151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,2646,311,1.21 [1.02-1.43],0.0261035362728586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,2630,305,1.37 [1.03-1.83],0.0314398241904087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,2648,308,2.21 [1.30-3.74],0.0032464933360306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,2267,249,1.42 [1.14-1.76],0.0017862678377629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,2268,253,1.15 [1.02-1.29],0.0183735295753106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,2646,311,0.79 [0.64-0.98],0.0333774281878596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,2638,309,1.40 [1.02-1.92],0.0348384716837919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,2585,303,2.09 [1.52-2.87],5.980267652584476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,2668,312,1.43 [1.17-1.74],0.0003913920354603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,2286,255,1.41 [1.14-1.75],0.0016372124475283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2655,309,1.70 [1.31-2.22],8.54402811377976e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,2673,312,2.86 [2.16-3.80],3.3098962363715337e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,2585,303,1.18 [1.00-1.39],0.0476437105015618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,2658,311,0.65 [0.44-0.97],0.0343391304252358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,2202,248,1.63 [1.19-2.23],0.0024886230686265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,2648,308,1.43 [1.12-1.83],0.0042716282098017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,2581,302,1.26 [1.11-1.44],0.0003220038035344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,2274,254,1.32 [1.07-1.64],0.0102536430014158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,2630,309,1.78 [1.34-2.37],7.546173818263179e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,2668,312,1.69 [1.50-1.91],3.226845388031793e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2674,311,2.19 [1.78-2.71],2.323886828323934e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,2674,311,1.35 [1.10-1.66],0.0043419722199586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,2278,254,1.59 [1.22-2.07],0.0005184444350023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",2641,310,1.46 [1.30-1.65],4.919703531197085e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,2674,311,0.77 [0.63-0.94],0.0103483974832516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,2639,307,1.64 [1.33-2.03],4.802814702379181e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2649,308,1.70 [1.43-2.04],4.572811524200278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,2230,249,1.57 [1.07-2.30],0.0218356126944247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,2267,249,0.70 [0.49-0.99],0.0443626171537006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,2631,310,2.32 [1.90-2.84],1.954457051086107e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,2274,254,1.31 [1.13-1.52],0.000280105749321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,2564,302,1.35 [1.08-1.68],0.0088165234218044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,2657,309,0.78 [0.64-0.95],0.0125446559915696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,2648,308,1.54 [1.13-2.10],0.0066225133041042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,2274,254,1.32 [1.05-1.65],0.0179212811897191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,2648,308,1.49 [1.13-1.96],0.004364418908497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,2646,308,1.73 [1.25-2.39],0.0008502913593964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,2649,308,1.69 [1.45-1.97],1.1259584323825648e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,2638,309,1.33 [1.07-1.65],0.009108921150122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,2652,308,1.40 [1.04-1.90],0.0277054551139964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,2646,311,3.09 [2.21-4.32],4.8337116255887955e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,2274,254,2.14 [1.57-2.91],1.2343779948674397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,2565,306,1.22 [1.04-1.41],0.0118363592728765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2662,312,1.41 [1.08-1.84],0.0118683696254839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,2648,308,1.52 [1.19-1.94],0.0008236063876118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2234,253,1.32 [1.05-1.67],0.0173366801590547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2679,313,1.96 [1.49-2.59],1.4722200109916226e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2636,308,1.64 [1.22-2.19],0.000988665737468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,2642,307,1.52 [1.24-1.87],6.009346578397306e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,2617,304,1.58 [1.16-2.15],0.0034748105463802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2583,300,1.18 [1.03-1.36],0.0178211179141475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,2273,252,1.91 [1.41-2.57],2.603704912681392e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,2658,311,1.51 [1.07-2.11],0.0177929743567624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,2581,302,1.25 [1.03-1.52],0.022464784822847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,2655,309,1.75 [1.36-2.25],1.4130779520996269e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,2651,310,1.42 [1.21-1.67],2.354738995830456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,2648,308,0.91 [0.84-0.99],0.0279815903157033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,2649,308,0.56 [0.40-0.79],0.000852738826198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,2674,311,1.52 [1.06-2.19],0.0241278599923912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,2242,246,1.61 [1.13-2.30],0.0086440556530121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,2661,313,1.40 [1.15-1.71],0.0007365453132642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2646,311,1.16 [1.07-1.26],0.0002824879701194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,2585,303,1.33 [1.10-1.61],0.0029505059481056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,2551,302,1.22 [1.08-1.37],0.0008687481802609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,2648,308,1.26 [1.07-1.49],0.0051446388237716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,2652,311,1.44 [1.22-1.71],2.5116683380495064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,2581,302,1.51 [1.12-2.03],0.0069060631779805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,2273,252,1.24 [1.03-1.50],0.0254694064038647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,2661,313,1.33 [1.12-1.59],0.0015516489314301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,2599,303,1.67 [1.36-2.04],8.311092314577692e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,2251,250,0.66 [0.46-0.95],0.0265081982235515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,2263,249,0.71 [0.53-0.95],0.0216454674488659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,2287,256,2.07 [1.41-3.02],0.0001774410754161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,2673,312,1.61 [1.30-2.00],1.2561939686813212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,2581,302,1.77 [1.55-2.03],1.3947662626614018e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",2273,252,1.21 [1.04-1.40],0.0145799479909773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,2230,249,1.23 [1.05-1.45],0.0114682422345868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,2230,249,1.36 [1.12-1.66],0.0022050916856909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2234,253,1.29 [1.07-1.55],0.0064984679597179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,2202,248,1.26 [1.01-1.57],0.0408741770303069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,2242,246,1.14 [1.00-1.30],0.0480081132111654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,2223,249,0.72 [0.57-0.90],0.0043224946050806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2658,311,2.17 [1.59-2.96],8.837983882724444e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,2673,312,0.53 [0.42-0.67],1.724277078618948e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,2642,310,1.80 [1.42-2.28],9.460068982463376e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2268,253,2.06 [1.50-2.83],8.036705995141524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,2668,312,2.85 [2.07-3.92],1.079153017447126e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2583,300,1.17 [1.05-1.31],0.0050524198232456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,2202,248,1.21 [1.01-1.44],0.0361870799869575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,2647,307,2.20 [1.69-2.85],3.173484487668514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,2658,311,1.87 [1.53-2.29],1.1121890890088316e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,2574,301,1.90 [1.60-2.26],2.332443536296199e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,2658,311,0.59 [0.48-0.72],4.513709687778077e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,2674,311,2.54 [1.90-3.40],4.1350042301095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,2202,248,1.11 [1.01-1.23],0.0379492387903724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",2581,302,1.26 [1.07-1.49],0.0068707502873003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",2581,302,1.23 [1.05-1.43],0.0103137602737491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,2679,313,2.37 [1.33-4.20],0.0032868957307579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,2251,253,2.15 [1.55-3.00],5.728263825369419e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,2648,308,1.72 [1.36-2.16],5.090552040374057e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,2668,312,1.34 [1.15-1.56],0.0001719164298508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,2648,308,1.71 [1.27-2.30],0.0003530327582432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,2655,309,2.13 [1.51-2.99],1.4333963528779903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2278,254,1.47 [1.08-1.99],0.0130782317930139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2648,308,1.14 [1.06-1.23],0.0004786898103792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,2274,254,1.38 [1.07-1.78],0.0128058628481738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,2661,313,1.61 [1.32-1.95],2.2257148686923942e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,2665,309,0.71 [0.58-0.88],0.001774070242383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,2639,307,0.76 [0.66-0.88],0.0001532266393586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,2655,309,1.84 [1.17-2.89],0.0083424661138694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,2577,302,0.82 [0.71-0.96],0.0104550601273975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,2256,250,1.73 [1.24-2.41],0.0012057634062655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,2278,254,1.72 [1.30-2.28],0.0001291554254202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,2585,303,0.80 [0.65-0.99],0.0428534989311999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2268,253,1.57 [1.08-2.28],0.0181912098200552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2239,245,0.77 [0.61-0.98],0.0323031624396291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,2662,311,1.63 [1.10-2.41],0.0149238152306072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,2274,254,2.22 [1.39-3.54],0.0008157696189095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,2648,308,1.34 [1.06-1.69],0.0137667898183867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,2268,253,1.87 [1.45-2.41],1.7131705479808997e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,2268,253,0.71 [0.51-0.98],0.0367587729726427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,2664,310,1.31 [1.07-1.60],0.0091454960341242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,2639,307,2.32 [1.77-3.02],6.265575242201985e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,2648,308,1.26 [1.06-1.50],0.0096799686453031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,2648,308,1.98 [1.45-2.71],2.005927873902093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,2674,311,2.17 [1.58-2.99],1.6631491743514728e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2268,253,1.51 [1.19-1.90],0.000554785623186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2634,311,1.51 [1.10-2.08],0.0113221799221478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,2613,307,1.21 [1.05-1.41],0.0112715710040359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,2624,307,2.00 [1.57-2.56],2.1790216040446705e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2661,313,2.62 [2.03-3.38],1.460546646312374e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2661,313,1.59 [1.26-2.01],9.894900665907764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2648,308,1.35 [1.12-1.61],0.0013220417877254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2242,246,0.76 [0.64-0.90],0.0011514179540755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,2273,252,2.28 [1.49-3.49],0.000139099763311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,2634,311,1.43 [1.21-1.69],2.5086462848354604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,2661,313,0.41 [0.32-0.53],8.512510421456428e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,2671,313,0.65 [0.55-0.78],3.848614552510548e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,2636,308,2.27 [1.64-3.16],8.987520941148955e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",2278,254,0.78 [0.64-0.96],0.0177902290711868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,2648,308,1.38 [1.10-1.74],0.0054881935439721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,2665,312,2.85 [2.11-3.84],8.161369579507324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,2214,250,1.71 [1.38-2.12],8.954686614789751e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2639,307,1.42 [1.12-1.81],0.0041550961290938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,2287,256,0.51 [0.34-0.76],0.0011021204879142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,2665,309,0.68 [0.51-0.91],0.008607478985156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2274,254,1.66 [1.32-2.08],1.2253562103426882e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,2644,307,1.16 [1.06-1.27],0.0010547489383111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,2286,255,1.92 [1.41-2.61],3.442022286141977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,2666,312,1.50 [1.15-1.96],0.0030023956587236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,2585,303,1.37 [1.01-1.85],0.040281335517438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,2649,308,1.80 [1.22-2.67],0.0031234503028461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,2286,255,1.31 [1.06-1.62],0.0107973380502097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,2214,250,1.42 [1.07-1.88],0.0148579335340152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,2641,308,1.39 [1.09-1.76],0.0069360546209703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,2278,254,0.60 [0.45-0.81],0.0007071647122884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,2647,309,1.76 [1.40-2.21],9.001148415347526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,2267,254,1.97 [1.31-2.97],0.001243043316881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2634,311,1.25 [1.14-1.37],2.226968948633658e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,2622,305,1.89 [1.49-2.41],1.7619912424870137e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2646,311,1.34 [1.09-1.66],0.0052681507497754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,2581,302,1.76 [1.36-2.28],2.1086602830174628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2273,252,1.64 [1.12-2.40],0.0109679683046741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2268,253,1.39 [1.10-1.75],0.0052428416909577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2627,309,1.52 [1.17-1.97],0.0016948271471205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,2646,311,1.41 [1.11-1.77],0.0039893187989541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,2202,248,1.26 [1.14-1.38],3.213816108321448e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,2652,312,1.78 [1.24-2.55],0.0018735563268182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,2646,311,0.62 [0.51-0.77],6.664232480193914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,2583,300,1.69 [1.28-2.23],0.0002462021992071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,2274,254,1.51 [1.22-1.88],0.0001811668232791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,2600,308,0.75 [0.65-0.87],0.0001606730194736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,2639,307,1.28 [1.14-1.43],4.1556594519258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,2268,253,1.25 [1.05-1.47],0.0097033977641704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,2628,304,1.95 [1.69-2.24],2.598649005806196e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,2679,313,1.61 [1.41-1.85],3.9763212737424695e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,2679,313,1.48 [1.30-1.68],1.3074339410860855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,2267,249,1.38 [1.03-1.84],0.0286910742339824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,2656,308,1.97 [1.70-2.27],1.3636851553771708e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2661,313,1.68 [1.26-2.24],0.0004258759970736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,2648,308,1.43 [1.30-1.56],5.922554956097987e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2251,250,1.25 [1.09-1.45],0.0021642154858511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,2673,312,1.67 [1.24-2.23],0.0005944555607647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,2673,312,1.72 [1.27-2.35],0.0005230818095818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,2274,254,1.32 [1.11-1.56],0.0015434193057813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,2287,256,2.21 [1.50-3.27],6.462472782803605e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,2207,250,1.68 [1.13-2.50],0.0096265157175916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,2273,255,1.68 [1.35-2.09],3.67963974894225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,2671,313,2.14 [1.68-2.72],5.462878446229526e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,2230,249,2.06 [1.46-2.91],3.93977840123552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,2656,308,1.47 [1.05-2.07],0.0267965479133639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2648,308,1.65 [1.24-2.19],0.0005963230078703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,2668,312,1.74 [1.29-2.34],0.0002787800222372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,2668,312,2.02 [1.52-2.67],1.079889929452773e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,2603,303,1.27 [1.10-1.47],0.0009094440843762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,2278,252,0.33 [0.16-0.66],0.0017591610584498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,2673,312,2.90 [2.23-3.79],4.382291045670533e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,2576,305,2.08 [1.66-2.60],1.8901957697245927e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,2679,313,1.27 [1.00-1.60],0.0477182164433718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,2673,312,2.24 [1.69-2.97],1.7113554736412572e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,2660,312,2.16 [1.69-2.77],1.1935681638120403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,2657,309,1.31 [1.09-1.57],0.0038085799761327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,2585,303,1.80 [1.52-2.13],9.461743385226372e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,2234,253,1.52 [1.22-1.90],0.0002043396040739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,2648,308,0.70 [0.57-0.86],0.0007839082042267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,2230,249,1.80 [1.45-2.25],1.9000664003692254e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,2278,252,0.43 [0.25-0.74],0.0022870373644521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,2648,308,1.48 [1.04-2.10],0.0285477081491402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,2671,313,1.67 [1.25-2.23],0.0004618284967183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,2275,254,2.02 [1.45-2.82],2.962392340637479e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,2679,313,0.85 [0.73-0.99],0.0384982513938803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,2241,246,0.60 [0.39-0.92],0.0184511566836948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2626,310,0.60 [0.42-0.85],0.0047327075083404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,2658,311,1.65 [1.19-2.29],0.0025437361918745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,2629,310,1.31 [1.06-1.61],0.0109189506881728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,2239,249,1.17 [1.00-1.36],0.0433851126266345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,2286,255,2.04 [1.46-2.87],3.4112801930594366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,2665,309,1.36 [1.08-1.72],0.0085613262860339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2646,311,1.52 [1.17-1.97],0.0017522645547127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2668,312,1.91 [1.44-2.54],8.487000253824685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2649,310,1.34 [1.11-1.62],0.0025001557113713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,2644,308,1.54 [1.27-1.88],1.5958481787486383e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,2585,303,1.45 [1.22-1.72],1.9199978383566733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,2646,311,1.27 [1.08-1.49],0.0044739994647204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,2583,300,1.31 [1.09-1.58],0.003918375202619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,2581,302,1.23 [1.05-1.45],0.0117242429256344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,2234,253,1.24 [1.00-1.54],0.049068125124971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,2581,302,1.34 [1.07-1.67],0.0108545674572748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2199,248,1.26 [1.04-1.52],0.0161037848427968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,2668,312,1.61 [1.26-2.04],0.0001200301220929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,2603,303,1.82 [1.40-2.36],6.188765864597277e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2265,252,1.40 [1.04-1.89],0.0259173137762334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,2639,307,0.35 [0.21-0.58],5.384193239867689e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,2581,302,1.17 [1.02-1.34],0.0245738097940064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,2668,312,1.37 [1.02-1.83],0.0356219697214378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,2665,309,1.47 [1.17-1.85],0.0008865657881133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,2666,309,1.21 [1.00-1.46],0.049013061375255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2267,249,0.81 [0.66-0.99],0.0382764699076323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,2274,254,0.78 [0.63-0.97],0.0251033138275448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,2634,311,1.44 [1.25-1.66],6.921169826743301e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2230,249,1.61 [1.17-2.22],0.0037127507671938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,2583,300,1.75 [1.38-2.23],4.666857185817351e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,2661,313,1.99 [1.70-2.32],5.0624327194552864e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,2646,311,1.64 [1.45-1.84],4.179514016612783e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,2654,312,1.50 [1.07-2.10],0.0184033180144952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,2665,309,1.58 [1.24-2.02],0.0002104991308595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,2634,311,0.42 [0.29-0.60],1.788421109804152e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,2656,308,1.89 [1.44-2.46],3.445289275571496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,2640,307,1.73 [1.34-2.24],2.579291993448406e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,2251,250,1.14 [1.00-1.28],0.0437245512368994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2639,307,1.46 [1.21-1.75],7.472999138067475e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,2661,313,1.70 [1.24-2.34],0.0010230438422259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,2342,273,1.80 [1.27-2.56],0.0010114890934783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,2639,307,1.64 [1.31-2.05],1.538527375435539e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2632,310,0.85 [0.77-0.93],0.0007309393503604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,2674,313,2.10 [1.56-2.83],1.1201646605103958e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,2650,313,1.37 [1.24-1.51],8.647922040203211e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,2660,308,1.55 [1.35-1.78],4.821322150971031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,2632,308,1.74 [1.50-2.02],3.101784365838856e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,2651,307,1.30 [1.02-1.65],0.0314050848459006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,2646,311,1.42 [1.18-1.72],0.0002782961642558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2630,305,0.57 [0.40-0.80],0.0015291970008298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,2658,311,1.84 [1.49-2.27],1.0220821072206932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,2679,313,1.37 [1.01-1.87],0.044058400991291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2287,256,1.87 [1.25-2.79],0.0021738881774659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,2197,248,0.84 [0.71-0.99],0.0334267979269591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,2648,308,1.64 [1.23-2.19],0.0008444528387825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,2661,313,1.27 [1.04-1.54],0.0187358808154203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,2673,312,1.67 [1.23-2.26],0.0010299238689935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2251,250,1.22 [1.00-1.48],0.0450990738867827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2655,309,0.77 [0.62-0.96],0.0218195899497466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,2612,306,1.39 [1.02-1.90],0.0372175172971984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,2273,252,1.43 [1.02-2.00],0.0384759068009179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2644,307,1.87 [1.22-2.86],0.0037915661323137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,2639,307,1.32 [1.19-1.47],4.0817566389577364e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,2661,313,1.17 [1.02-1.34],0.0299162434748036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,2601,302,1.28 [1.01-1.62],0.04005271635047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2634,311,1.90 [1.54-2.35],2.471106990419941e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2634,311,1.37 [1.22-1.54],1.3333443429431304e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2674,311,2.11 [1.74-2.56],5.16828542457453e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2649,308,1.65 [1.23-2.22],0.0009328539882728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2658,311,2.02 [1.60-2.54],2.4001932665051822e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2656,308,1.50 [1.17-1.92],0.0014482463886392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2585,303,1.29 [1.02-1.62],0.0304363669516853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2656,308,2.19 [1.72-2.79],2.819606631727101e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2242,246,1.35 [1.02-1.78],0.0370398462719994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2668,312,1.88 [1.50-2.36],4.734062458043446e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2661,313,2.56 [2.00-3.28],1.0241745591037945e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2661,313,1.53 [1.29-1.80],5.848173129446804e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2673,312,1.89 [1.37-2.61],0.0001167108032813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2669,311,1.97 [1.59-2.43],4.866319554447944e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2634,311,1.26 [1.07-1.49],0.0059892608677801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2673,312,1.43 [1.17-1.76],0.0006127913339184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2634,311,1.58 [1.31-1.89],8.511497355030282e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,2674,311,0.58 [0.40-0.84],0.00393835266267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2646,311,0.77 [0.65-0.91],0.0020098355449557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2674,311,0.60 [0.42-0.86],0.0046463154663964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2665,309,2.31 [1.64-3.24],1.6517073054993426e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2286,255,1.45 [1.07-1.95],0.0154037926811198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,2661,313,0.65 [0.45-0.94],0.0235438940657976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,2648,308,0.85 [0.75-0.97],0.0133495743507629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,2202,248,1.32 [1.12-1.55],0.0006892746624545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,2673,312,1.17 [1.01-1.36],0.0355552171404474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2214,250,1.35 [1.11-1.64],0.00305551593054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,2202,248,1.15 [1.02-1.29],0.0237613441448418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,2634,311,1.81 [1.44-2.28],5.040122982823288e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,2666,310,0.72 [0.61-0.85],0.0001120419452145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,2273,252,0.87 [0.77-0.99],0.0321324503924961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2278,254,1.43 [1.08-1.89],0.0115381544789792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,2602,300,2.02 [1.45-2.81],3.516150300968681e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,2653,308,1.85 [1.34-2.55],0.0001756491062257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,2670,310,1.93 [1.51-2.46],1.4958383540622306e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,2287,256,0.84 [0.72-0.98],0.0249430727388104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2267,249,1.36 [1.18-1.57],1.86324120991261e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2656,312,1.84 [1.50-2.24],2.8812814756954673e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,2278,254,0.68 [0.51-0.92],0.0123138143437642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,2581,302,1.25 [1.03-1.52],0.0245141017398667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2603,303,1.22 [1.06-1.41],0.0058186113098138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2583,300,1.45 [1.10-1.91],0.0080991521271132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,2630,310,1.41 [1.12-1.78],0.0033389394374992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,2274,254,1.30 [1.05-1.60],0.015586618119584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,2267,249,0.64 [0.44-0.94],0.0232401221302483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,2665,312,1.17 [1.01-1.35],0.0346935924934349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,2518,287,1.79 [1.48-2.16],1.924239117386593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2626,310,0.74 [0.59-0.93],0.0084023176276169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,2668,312,0.57 [0.42-0.76],0.0001597718822971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,2585,303,1.86 [1.49-2.32],4.3467136613476766e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,2668,312,1.32 [1.12-1.56],0.001072664738535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,2667,312,1.82 [1.42-2.34],2.979337828336863e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2658,311,0.89 [0.81-0.97],0.0111763429139467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,2278,254,2.57 [1.79-3.69],2.830214581564467e-07
